Fingerprint
Dive into the research topics where Bo Kong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Mutation of PXR phosphorylation motif at Ser347 disrupts lipid and bile acid homeostasis in diet-induced metabolic dysfunction–associated steatohepatitis in mice
Basaly, V., Henry, Z. R., Taylor, R. E., Kong, B., Yang, I., Brinker, A., Yang, Z., Zhou, P., Joseph, L. B., Aleksunes, L., Buckley, B., Negishi, M. & Guo, G. L., Feb 2026, In: Drug Metabolism and Disposition. 54, 2, 100222.Research output: Contribution to journal › Article › peer-review
Open Access -
Deletion of hepatic FXR leads to more severe MASH development in female mice
Henry, Z. R., Armstrong, L., Maliha, S., Jia, X., Gao, S., Taylor, R. E., Basaly, V., Otersen, K., Yang, Z., Rizzolo, D., Stofan, M., Meadows, V., Bhattacharya, A., Zhou, P., Yang, I., Brinker, A., Zhou, L., Zhu, H., Joseph, L. B. & Buckley, B. & 4 others, , May 16 2025, In: Hepatology Communications. 9, 6, e0693.Research output: Contribution to journal › Article › peer-review
3 Link opens in a new tab Scopus citations -
Editorial: The role of tumor microenvironment in malignant progression and target validation
Zhang, X., Zhang, X., Zhang, W., Kong, B., Sun, R. & Du, Q., 2025, In: Frontiers in Pharmacology. 16, 1656765.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Fibroblast growth factor 15 overexpression and combined peroxisome proliferator–activated receptor α activation attenuates metabolic dysfunction–associated steatohepatitis progression in mice
Shi, H., Stofan, M., Kong, B., Taylor, R., Henry, Z., Maliha, S., Rizzolo, D. & Guo, G. L., Sep 2025, In: Drug Metabolism and Disposition. 53, 9, 100128.Research output: Contribution to journal › Article › peer-review
Open Access -
Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXR
Henry, Z. R., Maliha, S., Basaly, V., Yang, Z., Taylor, R. E., Otersen, K., Meadows, V., Rizzolo, D., Stofan, M., Bhattacharya, A., Zhou, P., Brinker, A., Yang, I., Zhang, L., Joseph, L. B., Buckley, B., Kong, B. & Guo, G. L., Sep 29 2025, In: eGastroenterology. 3, 3, e100227.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations